GSK3B and lung cancer: Sulforaphane has been shown to decrease the levels of miR-616-5p and GSK3β/β-catenin signaling and to increase S/G2–M phase cell cycle arrest in lung cancer cell lines H1299, 95-C, and 95-D [264].